Durable survival and deep, lasting remissions in checkpoint-refractory, heavily pretreated cancers with median OS of ~23 months with agenT-797 ...
UCLA researchers have developed a new kind of immunotherapy that harnesses the body’s immune system to fight cancer more effectively. The innovative cell therapy uses specially engineered immune cells ...
Researchers at UCLA have developed a powerful new weapon in the battle against kidney cancer. Instead of relying on treatments tailored to each patient, this innovation uses specially engineered ...
BioWorld - Thursday, October 23, 2025 Breaking News: Trump administration impacts continue to roil the life sciences sector See today's BioWorld Science Home » Study evaluates allogeneic ...
The Chosun Ilbo on MSN
Myongji Hospital's Immune Cell Therapy Shrinks Tumors, Boosts Survival
Myongji Hospital Cell Therapy Center has gained positive responses from cancer patients by applying immune cell therapy. The ...
Glioblastoma, the most aggressive and lethal form of brain cancer in adults, has long evaded effective treatment due to its resistance to standard therapies, including surgical resection, radiation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback